Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

Condition:   Breast Cancer Intervention:   Drug: Inetetamab plus pyrotiniband and capecitabine Sponsor:   Yan Xue Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials